
Peptique Europe
Retatrutide Vial 20 mg
20
Retatrutide is a research peptide designed as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Its mechanism has made it a subject of scientific research involving metabolic mechanisms, energy balance, and receptor signaling.
138.00 €For research purposes only.
